#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Prader-Willi syndrome Neurotrophic keratopathy Cryoglobulinaemia Paroxysmal nocturnal haemoglobinuria Follicular lymphoma stage I Philadelphia positive chronic myeloid leukaemia Friedreich's ataxia PIK3CA related overgrowth spectrum Mantle cell lymphoma stage II Primary immunodeficiency syndrome Bronchopulmonary aspergillosis Neuroblastoma recurrent Synovial sarcoma Hypoparathyroidism Mantle cell lymphoma stage III More trials…

    Learn about Rare Diseases

    Extranodal marginal zone B-cell lymphoma (MALT type) – Basic Information Activated PI3 kinase delta syndrome – Treatment Mucopolysaccharidosis III – Basic Information Adrenocortical carcinoma VEXAS syndrome – Life with Disease Acute respiratory distress syndrome – Basic Information Mitochondrial myopathy – Treatment Pulmonary fibrosis – Basic Information Hereditary ataxia – Treatment Progressive supranuclear palsy – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Aminohippuric Acid MZE829 Lanreotide Dotatate (-)-PHENSERINE TARTRATE Midomafetamine Hydrochloride Ly3484356 VMX-C001 Alemtuzumab Anhydrous Caffeine Pf-07220060 Monohydrate Dacomitinib Verapamil Sot102 Tamoxifen MAGNESIUM ACETATE TETRAHYDRATE Clobetasol Oxybuprocaine Hydrochloride Basiliximab Fianlimab More therapies…

    Learn about Your Condition

    Schizophrenia Ebola disease Arterial tortuosity syndrome Synovial sarcoma metastatic HER2 positive breast cancer Hypoaesthesia Glycogen storage disorder Meningioma MELAS syndrome Malignant neoplasm of choroid Intestinal obstruction Chronic fatigue syndrome Sexual dysfunction Pleomorphic leiomyosarcoma Acute cardiac event More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Comparison of Oxazepam 50 mg orodispersible tablets and Oxazepam 50 mg standard tablets in healthy volunteers to test if they work the same way in the body

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Anxiety
    Investigated Drugs:
    • Oxazepam
    Portugal

  • Study of Descartes-08 compared to placebo in adults with generalized myasthenia gravis

    Not recruiting

    3 1
    Italy Poland Spain

  • Study of perineural incobotulinumtoxinA treatment for patients with Complex Regional Pain Syndrome type I or II affecting one side of the body

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    Denmark

  • Study of zorevunersen to reduce seizures in patients with Dravet syndrome

    Not recruiting

    3 1 1
    Investigated Drugs:
    • ZOREVUNERSEN SODIUM
    France Germany Italy Poland Spain Sweden

  • Study of drug interactions between leriglitazone, gemfibrozil, itraconazole, and carbamazepine and food effects in healthy male volunteers for adrenoleukodystrophy treatment

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Adrenoleukodystrophy
    Investigated Drugs:
    • Carbamazepine
    • Itraconazole
    • Leriglitazone
    Poland

  • Study comparing subcutaneous versus intravenous ublituximab in patients with relapsing multiple sclerosis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Relapsing multiple sclerosis
    Investigated Drugs:
    • Ublituximab
    Bulgaria Croatia Czechia Hungary
Previous Page
1 … 84 85 86 87 88 … 142
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!